Drugs / Autologous FMT
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT04188743 Comparator | Dec 2019 → Dec 2025 overdue | primary bacterial infectious disease | University Hospital, Ghent | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04188743 ↗ |
| Route | Other | “via naso-duodenal/-jejunal tube (Cortrak)” NCT04188743 ↗ |